Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa
Julio Rosenstock, Rattan Juneja, John M. Beals, et al.
Endocrine Reviews (2024) Vol. 45, Iss. 3, pp. 379-413
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial
Richard M. Bergenstal, Ruth S. Weinstock, Chantal Mathieu, et al.
The Lancet (2024) Vol. 404, Iss. 10458, pp. 1132-1142
Closed Access | Times Cited: 12
Once‐weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme
Richard M. Bergenstal, Athena Philis‐Tsimikas, Carol Wysham, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 8, pp. 3020-3030
Open Access | Times Cited: 11
Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment
Carol Wysham, Harpreet S. Bajaj, Stefano Del Prato, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 11
Once-Weekly Insulin: A Breakthrough in Diabetes Management or an Unresolved Challenge?
Raheel Ahmed, Aimen Shafiq, Mushood Ahmed
British Journal of Hospital Medicine (2025), pp. 1-6
Closed Access | Times Cited: 1
A peptide conjugate enables systemic injection of the morpholino inducer and more durable induction of T3H38 ribozyme-controlled AAV transgene in mice
Xiaojuan Tang, H. Wang, Yandong Yin, et al.
Gene Therapy (2025)
Closed Access | Times Cited: 1
Understanding the Pharmacokinetics and Glucodynamics of Once Weekly Basal Insulins to Inform Dosing Principles: An Introduction to Clinicians
Thomas R. Pieber, Jennifer Leohr, Juliana Bue‐Valleskey, et al.
Endocrine Practice (2024) Vol. 30, Iss. 9, pp. 863-869
Open Access | Times Cited: 4
Insulin Icodec: First Approval
Hannah A. Blair
BioDrugs (2024) Vol. 38, Iss. 5, pp. 717-724
Closed Access | Times Cited: 4
The rise of weekly insulins: addressing the challenges of type 2 diabetes care in Brazil
André Gustavo Daher Vianna, Diana Alves, Taís Silveira Assmann, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Perioperative and periprocedural management of once-weekly insulin treated patients
Robyn L. Houlden, Jeremy Gilbert, Tayyab Khan, et al.
Endocrine Practice (2025)
Closed Access
Once-Weekly Insulins
J. Hans DeVries, Tim Heise
Diabetes Technology & Therapeutics (2025)
Closed Access
Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)—Special Interest Group in Diabetes
Virginia Boccardi, Gülistan Bahat, Cafer Balcı, et al.
European Geriatric Medicine (2025)
Open Access
Once-weekly Basal Insulin Fc versus daily insulin degludec for glycemic control in diabetes: a systematic review, meta-analysis, and meta-regression
Sandesh Raja, Adarsh Raja, Azzam Ali, et al.
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access
Design of a novel long-acting insulin analogs by acetylation modification and compared with insulin Icodec
Min Yu, Chao Zhang, Hongjiang Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Niobium carbide MXenzyme for targeting disaggregation of human insulin fibrils and anti-inflammation
Yutong Ye, Yongli Ji, Chunyan Ma, et al.
International Journal of Biological Macromolecules (2025), pp. 142542-142542
Closed Access
Achievements in the Pathophysiology and Treatment of Insulin Resistance: Every Step Matters
George Dimitriadis
Nutrients (2025) Vol. 17, Iss. 7, pp. 1223-1223
Open Access
Once‐Weekly Insulin Versus Once‐Daily Insulin for Type 1 Diabetes Treatment: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
Obieda Altobaishat, Ahmed Farid Gadelmawla, Suliman Almohtasib, et al.
Endocrinology Diabetes & Metabolism (2025) Vol. 8, Iss. 3
Open Access
HbA1c reduction strategies: An overview of pharmacological interventions
Krishna Upadhye, Hariom Patidar, Narendra Bamnia, et al.
National Journal of Pharmacology and Therapeutics (2025) Vol. 3, Iss. 1, pp. 24-33
Closed Access
Structural Biophysics-Guided Computational Design of Semaglutide Analogues to Enhance GLP-1R Activation
Wei Li
(2025)
Closed Access
Advances in small-molecule insulin secretagogues for diabetes treatment
Jingqian Su, Jingran Xu, Shan Hu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117179-117179
Open Access | Times Cited: 3
Pharmacological and Benefit-Risk Profile of Once-Weekly Basal Insulin Administration (Icodec): Addressing Patients’ Unmet Needs and Exploring Future Applications
Ylenia Ingrasciotta, Giacomo Vitturi, Gianluca Trifirò
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 2113-2113
Open Access | Times Cited: 1
A New Once-Weekly Insulin — Its Effectiveness and Safety
Irwin Brodsky
New England Journal of Medicine (2024)
Closed Access | Times Cited: 1
Cost‐utility analysis of once‐weekly insulin icodec and once‐daily insulin glargine in patients with type 2 diabetes receiving basal‐bolus insulin therapy in China
Nan Dai, Xiaorong Su, Yong Wang
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 1
Splitting the chains: ultra-basal insulin analog uncovers a redox mechanism of hormone clearance
Michael A. Weiss
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Insulin icodec use in hospital settings: Considerations for once-weekly basal insulin therapy in hospital glycaemic management practice
Rahul Barmanray, Mervyn Kyi, Gerry Rayman, et al.
Diabetes Research and Clinical Practice (2024) Vol. 211, pp. 111660-111660
Closed Access
Toward once-monthly insulin therapy via synergy in two pharmacokinetic protractors: Fc-conjugation and fatty acid acylation
Alexander N. Zaykov, Vasily M. Gelfanov, Tina M. Tagmose, et al.
RSC Chemical Biology (2024) Vol. 5, Iss. 8, pp. 763-775
Open Access
Page 1 - Next Page

Scroll to top